Please assess the completion status of the following clinical trial:

Trial Title: Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* surgical extraction of \> 2 third molars with at least 1 complete or partial mandibular bony extraction~Exclusion Criteria:~* allergic response to aspirin, NSAIDs, acetaminophen or hydrocodone~* use of aspirin or other analgesics within 48 hours prior to surgery~* current or recent history of drug or alcohol abuse~* any medication for treatment of chronic pain~* clinically significant abnormality on screening laboratory test active or recent history of peptic ulcer disease or GI bleeding~* prior abdominal surgery, except uncomplicated appendectomy~* any other surgical procedure within 30 days before administration of study drug~* pregnancy or breastfeeding~* untreated hypertension; SBP \> 140 mmHg or DBP \> 95 mmHg

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): None
- N1539 15 mg (Type: EXPERIMENTAL): None
- N1539 30 mg (Type: EXPERIMENTAL): None
- N1539 60 mg (Type: EXPERIMENTAL): None
- Motrin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).